Clinical Controls, Inc.
FDA Regulatory Profile
Summary
- Total Recalls
- 0
- 510(k) Clearances
- 18
- Inspections
- 0
- Compliance Actions
- 0
Recent 510(k) Clearances
| K-Number | Device | Date |
| K012907 | LIQUISPX LIQUID SALIVA OR UNRINE DRUG OF ABUSE CONTROL | September 28, 2001 |
| K964278 | WHOLE BLOOD GLUCOSE CONTROL LEVEL 1,2,AND 3/WHOLE BLOOD GLUCOSE LINEARITY CONTROL-LEVEL1,2,3,4,5,AND | November 22, 1996 |
| K962432 | LIQUISPEX URINE (MICRO)ALBUMIN CONTROL | July 5, 1996 |
| K955691 | SERUM VOLATILES CONTROL LEVEL 1 & 2 | April 24, 1996 |
| K955690 | AQUEOUS ETHANOL/AMMONIA CONTROL LEVEL 1, 2, & 3 | April 24, 1996 |
| K946265 | FIBRINOGEN HIGH ABNORMAL CONTROL - LEVEL 3 | August 24, 1995 |
| K935598 | PLASMA FIBRINOGEN CONTROL LEVEL 1/LEVEL 2 | May 2, 1995 |
| K946049 | LIQUISPEX(TM) LIQUID B2M/CRP CONTROL LEVEL 1 AND 2 | February 10, 1995 |
| K946048 | LIQUISPEX(TM) LIQUID B2M CONTROL LEVEL 1 AND 2 | February 10, 1995 |
| K946050 | LIQUISPEX(TM) LIQUID CRP CONTROL LEVEL 1 AND 2 | February 10, 1995 |
| K946266 | FERRITIN CONTROL - LEVEL 1, 2, 3 | February 10, 1995 |
| K946144 | LIQUISPEX(TM) URINE ETHANOL CONTROL | February 8, 1995 |
| K946143 | CHEMSPEX(TM) AMMONIA CONTROL | February 3, 1995 |
| K946145 | CARDIOSPEX(TM) CKMB/LD-1 IMMUNOINHIBITION CONTROL | January 24, 1995 |
| K946146 | CARDIOSPEX(TM) LIQUID CKMB/LD-1 IMMUNOINHIBITION | January 24, 1995 |
| K944923 | CKMB/MYOGLOBIN MASS MEASUREMENY CONTROL LEVEL 1, 2, 3, | November 4, 1994 |
| K935599 | HCG/TSH CONTROL- LEVEL 1/LEVEL 2/LEVEL 3 | October 31, 1994 |
| K934741 | LIQUID FIBRINOGEN FDP CONTROL LEVEL 1 & 2 | September 8, 1994 |